Accelerate to discover

Back to filter

Related topics

Elevated NSD3 histone methylation activity drives squamous cell lung cancer

Spectral Instruments Imaging

Jun 8, 2021

This work identifies NSD3 as a principal 8p11-12 amplicon-associated oncogenic driver in LUSC, and suggests that...

Jun 20, 2021

IncuCyte webinar recording: How to measure Immune Cell Killing of Tumor Cells effectively

Sartorius

Jun 4, 2021

Immuno-oncology (IO) has transformed cancer treatment. The number of treatments in the IO pipeline continues to...

White Paper: Immunophenotyping Rare Immune Cells with Laminar Wash AUTO System

Curiox

Jun 3, 2021

The Laminar Wash (LW) AUTO system consists of a wall-less plate and a laminar flow cell washer that enable automated...

A subset of cytotoxic effector memory T cells enhances CAR T cell efficacy in a model of pancreatic

Tonbo Biosciences

Jun 3, 2021

Tonbo Biosciences flow cytometry reagents & antibodies are manufactured with the highest quality and precision and...

Jun 20, 2021

Cytek webinar : Evaluating Spectral Cytometry for Immune Profiling in Viral Disease

Cytek Biosciences

May 13, 2021

In conventional fluorescence cytometry, each fluorophore in a panel is measured in a target detector, through the use...

Show all topics (10)

Intelligent antibody discovery

Apr 4, 2016

With the promise of better specificity and safety, antibody-based drugs are a powerful tool for treating disease. But finding the best candidates to move through development can be time consuming and expensive. It’s not just about screening to find the highest-affinity binder, it’s also about finding the antibody that can promote the desired biological response while avoiding off-target binding and toxicity.

The iQue Screener speeds your antibody discovery programs by reducing screening time while increasing the amount and kind of data you can collect. In just a fraction of the time it takes to do a high-throughput ELISA—and using far less target protein—the iQue Screener not only provides quantitative binding information, it can also deliver data from cell-based assays that report on functions such as membrane integrity, cytokine release, and more. This comprehensive data set helps you make more informed decisions about potential leads faster, reducing discovery time, reducing discovery costs, and conserving valuable reagents.

Application
Product news

Related technologies: Conventional flow cytometry

Brand profile

IntelliCyt

IntelliCyt Corporation's high throughput flow technology is the first to enable screening suspension cells, beads, microbes and mixtures.

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey